This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Zymergen Management
Management criteria checks 0/4
Key information
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | n/a |
| Management average tenure | 1.2yrs |
| Board average tenure | no data |
Recent management updates
Recent updates
Zymergen chief scientific officer to depart as company lays off more employees
Aug 25Zymergen: Ginkgo Bioworks Acquisition
Jul 26Zymergen expands agreement with Octant on developing breakthrough medicines
Jul 14Zymergen Seeks Turnaround But Runway Is Running Low
Jun 03Zymergen: A Humbled Company With A Business On The Ropes
May 23Some Zymergen Inc. (NASDAQ:ZY) Analysts Just Made A Major Cut To Next Year's Estimates
Mar 27
Zymergen Inc. (NASDAQ:ZY) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Mar 25Zymergen: Total Chaos
Dec 09Zymergen: How To Buy A Disaster
Aug 05Analysts Just Made A Major Revision To Their Zymergen Inc. (NASDAQ:ZY) Revenue Forecasts
Aug 05Zymergen acquired Accelerator Life Science Partners’ portfolio company
May 28CEO
Zymergen has no CEO, or we have no data on them.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Financial Officer | 8.2yrs | US$5.13m | 0% $ 0 | |
| Chief Technology Officer | less than a year | no data | no data | |
| Director of Communications | no data | no data | no data | |
| Chief Commercial Officer | 1.2yrs | no data | no data | |
| Chief Development Officer | 1.2yrs | no data | no data | |
| Senior Vice President of Drug Discovery | less than a year | no data | no data | |
| Secretary | no data | no data | no data | |
| Corporate Secretary | no data | US$1.81m | 0.037% $ 94.2k |
1.2yrs
Average Tenure
Experienced Management: ZY's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.